Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Leukemia

  Free Subscription


Articles published in Exp Hematol

Retrieve available abstracts of 71 articles:
HTML format



Single Articles


    July 2022
  1. SOMMERKAMP P, Brown JA, Haltalli MLR, Mercier FE, et al
    m(6)A RNA modifications: Key regulators of normal and malignant hematopoiesis.
    Exp Hematol. 2022;111:25-31.
    PubMed     Abstract available


  2. UPADHYAY P, Beales J, Shah NM, Gruszczynska A, et al
    Recurrent transcriptional responses in AML and MDS patients treated with decitabine.
    Exp Hematol. 2022;111:50-65.
    PubMed     Abstract available


    June 2022
  3. JUNCO JJ, Zorman B, Gant VU Jr, Munoz J, et al
    CRLF2 overexpression results in reduced B-cell differentiation and upregulated E2F signaling in the Dp16 mouse model of Down syndrome.
    Exp Hematol. 2022;110:34-38.
    PubMed     Abstract available


    May 2022
  4. SOOF CM, Spektor TM, Parikh SA, Slager SL, et al
    Serum B-Cell Maturation Antigen is an Independent Prognostic Marker in Previously Untreated Chronic Lymphocytic Leukemia.
    Exp Hematol. 2022 May 4. pii: S0301-472X(22)00205.
    PubMed     Abstract available


  5. KATO H, Maezawa Y, Nishijima D, Iwamoto E, et al
    A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency.
    Exp Hematol. 2022;109:11-17.
    PubMed     Abstract available


    April 2022
  6. PERMATASARI HK, Nakahata S, Ichikawa T, Fauzi YR, et al
    Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma.
    Exp Hematol. 2022 Apr 11. pii: S0301-472X(22)00158.
    PubMed     Abstract available


  7. KROPP EM, Li Q
    Mechanisms of Resistance to Targeted Therapies for Relapsed or Refractory Acute Myeloid Leukemia.
    Exp Hematol. 2022 Apr 10. pii: S0301-472X(22)00133.
    PubMed     Abstract available


  8. REDONDO MONTE E, Leubolt G, Windisch R, Kerbs P, et al
    Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation.
    Exp Hematol. 2022;108:26-35.
    PubMed     Abstract available


  9. KLEMPNAUER KH
    C/EBPbeta sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module.
    Exp Hematol. 2022;108:8-15.
    PubMed     Abstract available


    March 2022
  10. GERRITSEN M, Hilgendorf S, Yi G, Wierenga ATJ, et al
    Presence of mutant p53 increases stem-cell frequency and is associated with reduced binding to classical TP53 binding sites in cell lines and primary AMLs.
    Exp Hematol. 2022 Mar 18. pii: S0301-472X(22)00128.
    PubMed     Abstract available


  11. SHABASHVILI DE, Feng Y, Kaur P, Venugopal K, et al
    Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations.
    Exp Hematol. 2022 Mar 16. pii: S0301-472X(22)00125.
    PubMed     Abstract available


  12. YAN Y, Upadhyaya R, Zhang VW, Berg T, et al
    Epigenetic Maintenance Strategies after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia.
    Exp Hematol. 2022 Mar 11. pii: S0301-472X(22)00122.
    PubMed     Abstract available


  13. PAREDES R, Doleschall N, Connors K, Geary B, et al
    EVI1 protein interaction dynamics: Targetable for therapeutic intervention?
    Exp Hematol. 2022;107:1-8.
    PubMed     Abstract available


    February 2022
  14. CAN I, Cox MJ, Siegler EL, Kenderian SS, et al
    Challenges of chimeric antigen receptor T-cell therapy in chronic lymphocytic leukemia: lessons learned.
    Exp Hematol. 2022 Feb 10. pii: S0301-472X(22)00069.
    PubMed     Abstract available


  15. SIMONSEN AT, Meggendorfer M, Hansen MH, Nederby L, et al
    Acute myeloid leukemia displaying clonal instability during treatment: implications for measurable residual disease assessments.
    Exp Hematol. 2022 Feb 2. pii: S0301-472X(22)00001.
    PubMed     Abstract available


  16. ALI A, Vaikari VP, Alachkar H
    CD99 in malignant hematopoiesis.
    Exp Hematol. 2022;106:40-46.
    PubMed    


  17. BIGAS A, Rodriguez-Sevilla JJ, Espinosa L, Gallardo F, et al
    Recent advances in T-cell lymphoid neoplasms.
    Exp Hematol. 2022;106:3-18.
    PubMed     Abstract available


    January 2022
  18. KAPADIA B, Shetty AC, Bollino D, Bhandary B, et al
    Translatome changes in acute myeloid leukemia cells post-exposure to pegcrisantaspase and venetoclax.
    Exp Hematol. 2022 Jan 29. pii: S0301-472X(22)00036.
    PubMed     Abstract available


  19. ZHANG J, Liu X, Yin C, Zong S, et al
    hnRNPK/Beclin1 signaling regulates autophagy to promote imatinib resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia cells.
    Exp Hematol. 2022 Jan 14. pii: S0301-472X(22)00032.
    PubMed     Abstract available


  20. LIU F, Zhao Q, Su Y, Lv J, et al
    Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance.
    Exp Hematol. 2022;105:39-49.
    PubMed     Abstract available


    December 2021
  21. THURGOOD LA, Best OG, Rowland A, Lower KM, et al
    Lipid uptake in chronic lymphocytic leukemia.
    Exp Hematol. 2021 Dec 8. pii: S0301-472X(21)00624.
    PubMed     Abstract available


  22. HE X, Zhang Y, Xu Y, Xie L, et al
    Function of the P2X7 receptor in hematopoiesis and leukemogenesis.
    Exp Hematol. 2021;104:40-47.
    PubMed     Abstract available


    November 2021
  23. KENSWIL KJG, Pisterzi P, Feyen J, Ter Borg M, et al
    Immune composition and its association with hematologic recovery after chemotherapeutic injury in acute myeloid leukemia.
    Exp Hematol. 2021 Nov 17. pii: S0301-472X(21)00426.
    PubMed     Abstract available


  24. MA Y, Chen Z, Yu J
    Pseudogenes and their potential functions in hematopoiesis.
    Exp Hematol. 2021;103:24-29.
    PubMed     Abstract available


    September 2021
  25. TREMBLAY CS, Ting SB, McCluskey A, Robinson PJ, et al
    Shutting the gate: targeting endocytosis in acute leukemia.
    Exp Hematol. 2021 Sep 23. pii: S0301-472X(21)00326.
    PubMed    


  26. LIAO W, Eric Kohler M, Fry T, Ernst P, et al
    Corrigendum to : <[Experimental Hematology 2021; 100: 1-11]>.
    Exp Hematol. 2021 Sep 20. pii: S0301-472X(21)00293.
    PubMed    


  27. MARIN-SANCHEZ A, Martinez-Fernandez G, Gomez-Catalan I, Montoya-Morcillo MC, et al
    Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
    Exp Hematol. 2021;101-102:49-57.
    PubMed     Abstract available


  28. LI Y, Magee JA
    Transcriptional reprogramming in neonatal hematopoietic stem and progenitor cells.
    Exp Hematol. 2021;101-102:25-33.
    PubMed     Abstract available


    August 2021
  29. LEVESQUE JP, Summers KM, Millard SM, Bisht K, et al
    Role of macrophages and phagocytes in orchestrating normal and pathologic hematopoietic niches.
    Exp Hematol. 2021;100:12-31.
    PubMed     Abstract available


    July 2021
  30. HONDA A, Koya J, Yoshimi A, Miyauchi M, et al
    Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemia.
    Exp Hematol. 2021 Jul 29. pii: S0301-472X(21)00280.
    PubMed     Abstract available


  31. LIAO W, Kohler ME, Fry T, Ernst P, et al
    Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia.
    Exp Hematol. 2021 Jul 21. pii: S0301-472X(21)00248.
    PubMed     Abstract available


    June 2021
  32. KAEHLER M, Dworschak M, Rodin JP, Ruemenapp J, et al
    ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells.
    Exp Hematol. 2021 Jun 3. pii: S0301-472X(21)00199.
    PubMed     Abstract available


  33. MACBETH KJ, Chopra VS, Tang L, Zheng B, et al
    Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA.
    Exp Hematol. 2021;98:47-52.
    PubMed     Abstract available


    May 2021
  34. GRANDITS AM, Wieser R
    Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.
    Exp Hematol. 2021 May 21. pii: S0301-472X(21)00195.
    PubMed     Abstract available


  35. YOKOMIZO-NAKANO T, Sashida G
    Two faces of RUNX3 in myeloid transformation.
    Exp Hematol. 2021;97:14-20.
    PubMed     Abstract available


  36. DI GENUA C, Nerlov C
    To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice.
    Exp Hematol. 2021;97:6-13.
    PubMed     Abstract available


    March 2021
  37. MONDET J, Presti CL, Chevalier S, Bertrand A, et al
    Mitochondria in human acute myeloid leukemia cell lines have ultrastructural alterations linked to deregulation of their respiratory profiles.
    Exp Hematol. 2021 Mar 6. pii: S0301-472X(21)00095.
    PubMed     Abstract available


    February 2021
  38. VILLAUME MT, Arrate MP, Ramsey HE, Sunthankar KI, et al
    The delta isoform of PI3K predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib.
    Exp Hematol. 2021 Feb 19. pii: S0301-472X(21)00089.
    PubMed     Abstract available


  39. SWART LE, Heidenreich O
    The RUNX1/RUNX1T1 network: translating insights into therapeutic options.
    Exp Hematol. 2021;94:1-10.
    PubMed     Abstract available


    January 2021
  40. WEI H, Liu X, Wang Y, Lin D, et al
    The Optimized Clinical Application of Minimal Residual Disease in Acute Myeloid Leukemia with RUNX1-RUNX1T1.
    Exp Hematol. 2021 Jan 29. pii: S0301-472X(21)00032.
    PubMed     Abstract available


  41. BATSIVARI A, Grey W, Bonnet PD
    Understanding of the crosstalk between normal residual hematopoietic stem cells and the leukemic niche in Acute Myeloid Leukemia.
    Exp Hematol. 2021 Jan 23. pii: S0301-472X(21)00026.
    PubMed     Abstract available


  42. RUSSKAMP NF, Myburgh R, Kiefer JD, Neri D, et al
    Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells.
    Exp Hematol. 2021 Jan 20. pii: S0301-472X(21)00004.
    PubMed     Abstract available


  43. MAKI H, Yoshimi A, Shimada T, Arai S, et al
    Physical interaction between BAALC and DBN1 induces chemoresistance in leukemia.
    Exp Hematol. 2021 Jan 14. pii: S0301-472X(20)30666.
    PubMed     Abstract available


  44. MILONE G, Scire P, Camuglia MG, Triolo A, et al
    LOW CONTENT OF CLONOGENIC PROGENITORS ON DAY+18, IS ASSOCIATED WITH ACUTE GRAFT VERSUS HOST DISEASE AND PREDICT TRANSPLANT RELATED MORTALITY.
    Exp Hematol. 2021 Jan 11. pii: S0301-472X(21)00003.
    PubMed     Abstract available


  45. BLANCO G, Puiggros A, Sherry B, Nonell L, et al
    CLL-like monoclonal B cell lymphocytosis displays an increased inflammatory signature that is reduced in early stage chronic lymphocytic leukemia.
    Exp Hematol. 2021 Jan 6. pii: S0301-472X(21)00001.
    PubMed     Abstract available


  46. AREDE L, Pina C
    Buffering noise: KAT2A modular contributions to stabilization of transcription and cell identity in cancer and development.
    Exp Hematol. 2021;93:25-37.
    PubMed     Abstract available


    November 2020
  47. CHIN PS, Assi SA, Ptasinska A, Imperato MR, et al
    RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia.
    Exp Hematol. 2020 Nov 2. pii: S0301-472X(20)30618.
    PubMed     Abstract available


    October 2020
  48. SYMEONIDOU V, Ottersbach K
    HOXA9/IRX1 expression pattern defines two sub-groups of infant MLL-AF4-driven Acute Lymphoblastic Leukemia.
    Exp Hematol. 2020 Oct 15. pii: S0301-472X(20)30593.
    PubMed     Abstract available


  49. FITCH B, Roy R, Geng H, Montecino-Rodriguez E, et al
    Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature.
    Exp Hematol. 2020;90:65-71.
    PubMed     Abstract available


    September 2020
  50. HENGEVELD PJ, Levin MD, Kolijn PM, Langerak AW, et al
    Reading the B cell receptor Immunome in Chronic Lymphocytic Leukemia: Revelations and Applications.
    Exp Hematol. 2020 Sep 22. pii: S0301-472X(20)30559.
    PubMed     Abstract available


  51. BOILA LD, Sengupta A
    Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
    Exp Hematol. 2020 Sep 17. pii: S0301-472X(20)30554.
    PubMed     Abstract available


  52. JACOBS S, Ausema A, Zwart E, Weersing E, et al
    Detection of chemotherapy-resistant patient-derived acute lymphoblastic leukemia clones in murine xenografts using cellular barcodes.
    Exp Hematol. 2020 Sep 15. pii: S0301-472X(20)30553.
    PubMed     Abstract available


  53. TANAKA Y, Mikami K, Adachi K, Fukushima T, et al
    Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells.
    Exp Hematol. 2020 Sep 7. pii: S0301-472X(20)30548.
    PubMed     Abstract available


  54. YOUNG K, Loberg MA, Eudy E, Schwartz LS, et al
    Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.
    Exp Hematol. 2020;89:61-67.
    PubMed     Abstract available


  55. ZANETTI C, Krause DS
    "Caught in the net": the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia.
    Exp Hematol. 2020;89:13-25.
    PubMed     Abstract available


  56. KANIYATTU SM, Meenakshi A, Kumar MB, Kumar KR, et al
    Cytogenetic and cytokine profile in elderly patients with cytopenia.
    Exp Hematol. 2020;89:80-86.
    PubMed     Abstract available


    August 2020
  57. LIN H, Damen JE, Walasek MA, Szilvassy SJ, et al
    A Feeder-Free and Serum-Free In Vitro Assay for Measuring the Effect of Drugs on Acute and Chronic Myeloid Leukemia Stem/Progenitor Cells.
    Exp Hematol. 2020 Aug 13. pii: S0301-472X(20)30349.
    PubMed     Abstract available


  58. HOSNIJEH FS, van der Straten L, Kater AP, van Oers MHJ, et al
    Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy; results from the HOVON 109 study.
    Exp Hematol. 2020 Aug 8. pii: S0301-472X(20)30308.
    PubMed     Abstract available


    July 2020
  59. BOTTARDI S, Guieze R, Bourgoin V, Fotouhi-Ardakani N, et al
    MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells.
    Exp Hematol. 2020 Jul 16. pii: S0301-472X(20)30269.
    PubMed     Abstract available


  60. YAN B, Claxton D, Huang S, Qiu Y, et al
    AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.
    Exp Hematol. 2020;87:13-19.
    PubMed     Abstract available


  61. DEUTSCH JL, Heath JL
    MLLT10 in benign and malignant hematopoiesis.
    Exp Hematol. 2020;87:1-12.
    PubMed     Abstract available


    June 2020
  62. HE X, Dou A, Feng S, Roman-Rivera A, et al
    Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro.
    Exp Hematol. 2020;86:21-27.
    PubMed     Abstract available


    May 2020
  63. SINHA R, Porcheri C, d'Altri T, Gonzalez J, et al
    Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.
    Exp Hematol. 2020 May 10. pii: S0301-472X(20)30146.
    PubMed     Abstract available


  64. LENARD A, Xie HM, Pastuer T, Shank T, et al
    Epigenetic regulation of protein translation in KMT2A-rearranged AML.
    Exp Hematol. 2020;85:57-69.
    PubMed     Abstract available


    April 2020
  65. PAGLIARO S, Desterke C, Acloque H, Chomel JC, et al
    SINGLE CELL TRANSCRIPTOME IN CHRONIC MYELOID LEUKEMIA (CML): PSEUDOTIME ANALYSIS REVEALS EVIDENCE OF EMBRYONIC AND TRANSITIONAL STEM CELL STATES.
    Exp Hematol. 2020 Apr 28. pii: S0301-472X(20)30142.
    PubMed     Abstract available


  66. RAZ O, Granot G, Pasmanik-Chor M, Raanani P, et al
    Profiling and Bioinformatics Analyses Reveal Chronic Lymphocytic Leukemia Cells Share a Unique Circular RNA Expression Pattern.
    Exp Hematol. 2020 Apr 10. pii: S0301-472X(20)30137.
    PubMed     Abstract available


    March 2020
  67. SWIERCZEK S, Prchal JT
    Clonal hematopoiesis in hematological disorders: Three different scenarios.
    Exp Hematol. 2020;83:57-65.
    PubMed     Abstract available


  68. COOK EK, Luo M, Rauh MJ
    Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity.
    Exp Hematol. 2020;83:85-94.
    PubMed     Abstract available


    February 2020
  69. KRONSTEIN-WIEDEMANN R, Klop O, Thiel J, Milanov P, et al
    K562 erythroleukemia line as a possible reticulocyte source to culture Plasmodium vivax and its surrogates.
    Exp Hematol. 2020;82:8-23.
    PubMed     Abstract available


    January 2020
  70. LEE-SIX H, Kent DG
    Tracking hematopoietic stem cells and their progeny using whole-genome sequencing.
    Exp Hematol. 2020 Jan 30. pii: S0301-472X(20)30024.
    PubMed     Abstract available


  71. AKAHOSHI Y, Nakasone H, Kawamura K, Kusuda M, et al
    Detection of T315I using digital polymerase chain reaction in allogeneic transplant recipients with Ph-positive acute lymphoblastic anemia in the dasatinib era.
    Exp Hematol. 2020 Jan 11. pii: S0301-472X(20)30001.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: